From July to August 2026, a commercial broiler farm trial was conducted in Cheongyang-gun, South Korea, to evaluate SUPERZYME (Multi-Carbohydrase) from CBS Bio Platforms.
Despite prolonged heat conditions exceeding 35°C, the SUPERZYME treatment group showed higher average body weight, improved feed conversion ratio (FCR), and an increased production index compared to the control group.
Through continuous trial research and R&D, MorningBio will keep delivering reliable, high-performance solutions to the livestock industry.
Thank you for your continued support.